Gefitinib plus Fuzheng Kang’ai Formula (扶正抗癌方) in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial
Crossref DOI link: https://doi.org/10.1007/s11655-017-2819-8
Published Online: 2017-08-09
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Xiao-bing
Chai, Xiao-shu
Wu, Wan-yin
Long, Shun-qin
Deng, Hong
Pan, Zong-qi
He, Wen-feng
Zhou, Yu-shu
Liao, Gui-ya
Xiao, Shu-jing
Text and Data Mining valid from 2017-08-09